Insmed | INSM - Assets

Stock Price
109.14
Daily Change
-6.48 -5.60%
Monthly
-23.57%
Yearly
60.22%
Q2 Forecast
106.95

Insmed reported $2.08B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
BioMarin Pharmaceutical USD 8.59B 996.99M Mar/2026
Cytokinetics USD 1.27B 151.06M Mar/2026
DBV Technologies USD 233.72M 123.22M Dec/2025
Gilead Sciences USD 56.28B 2.74B Mar/2026
Heron Therapeutics USD 246.22M 9.66M Mar/2026
Insmed USD 2.08B 188.7M Mar/2026
Novartis USD 110.95B 3.66B Dec/2025
Regeneron Pharmaceuticals USD 40.87B 310.1M Mar/2026
Sarepta Therapeutics USD 3.18B 170.77M Mar/2026
Ultragenyx Pharmaceutical USD 1.3B 236M Mar/2026
Vertex Pharmaceuticals USD 26.48B 841.4M Mar/2026